
After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …

After more than a month of uncertainty, Takeda has finally confirmed it has managed to successfully acquire Shire, agreeing on …

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

The year seems like it’s running away as we come to the end of April. It’s been a more tense …

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …

Just in time for the first good weather of the year, the May 2018 edition of Pharmafocus is available to …

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …

Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that …

Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …

It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …

Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …